Swiss GDP grew 1.5% in Q2, surpassing forecasts and driven by pharmaceuticals and chemicals. Pharma giants Novartis and Roche posted earnings beats, reinforcing the sector's contribution to national e
The U.S. may launch a Section 301 trade investigation into Switzerland's pharmaceutical sector over potential price cuts, mirroring actions against Germany. Industry leaders warn this could impact maj
Swiss companies invested $27 billion in the U.S. between January and April following a tariff agreement reducing duties on Swiss goods. Major pharmaceutical firms Novartis and Roche announced new faci
ChemBrief